Reduction in podocyte density as a pathologic feature in early diabetic nephropathy in rodents: Prevention by lipoic acid treatment
2006

Podocyte Loss in Early Diabetic Nephropathy and Prevention by Antioxidants

Sample size: 6 publication Evidence: moderate

Author Information

Author(s): Siu Brian, Saha Jharna, Smoyer William E, Sullivan Kelli A, Brosius Frank C III

Primary Institution: University of Michigan

Hypothesis

Streptozotocin diabetes in rats and mice would result in an early reduction in podocyte density and that this reduction would be prevented by antioxidants.

Conclusion

The study found that streptozotocin diabetes leads to a significant reduction in podocyte density within 2 weeks, which can be prevented by antioxidant treatment.

Supporting Evidence

  • Podocyte density was significantly reduced in diabetic rats at 2, 6, and 8 weeks after STZ injection.
  • Treatment with α-lipoic acid substantially prevented podocyte loss in diabetic rats.
  • Insulin treatment had only a modest effect on maintaining podocyte number.

Takeaway

When rats and mice get diabetes, they lose important kidney cells called podocytes quickly, but giving them a special vitamin can help keep those cells safe.

Methodology

The study measured podocyte density in diabetic rats and mice at various time points and assessed the effects of insulin and α-lipoic acid treatments.

Limitations

The study did not survey glomerular serial sections and did not investigate both thick and thin sections of the same glomerulus.

Participant Demographics

Male Wistar rats and C57BL/6 mice were used in the experiments.

Statistical Information

P-Value

p<0.01

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1471-2369-7-6

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication